In a report released on July 30, Nicolas Pauillac from Kepler Capital maintained a Hold rating on GlaxoSmithKline, with a price target of p1,500.00. The company’s shares closed yesterday at p1,418.00.

President Donald Trump just sent letters to heads of 17 major pharmaceutical companies pushing them to drop drug prices in ...

The pharmaceutical industry continues to evolve rapidly, driven by innovation, global health challenges, and technological ...

The poll found one in five over-65s either did not know what shingles was or were unaware the NHS offered a vaccine to ...

Just hours before the midnight deadline, the White House unveiled its updated trade policy, reaffirming a 10% "universal" ...

Hello, Jason here. Welcome to today’s edition of The Business Roundup, your go-to digest for key local and international ...